pharmacokinetic study of mycophenolic acid in iranian kidney transplant patients.

Authors

kheirollah gholami clinical pharmacy department, faculty of pharmacy and research center for rational use of drugs, tehran university of medical sciences, tehran, iran

mohammadreza rouini department of pharmaceutics, faculty of pharmacy, tehran university of medical sciences, tehran, iran

niayesh mohebbi clinical pharmacy department, faculty of pharmacy, tehran university of medical sciences, tehran, iran

iman karimzadeh clinical pharmacy department, faculty of pharmacy, tehran university of medical sciences, tehran, iran

abstract

background: the purpose of this study was to characterize the pharmacokinetic parameters of mycophenolic acid (mpa) in iranian kidney transplant patients. methods: plasma mpa concentration of mycophenolate mofetile (mmf) 1 gram two times a day was measured in 21 iranian kidney transplant recipients receiving treatment. patients who entered the study had been transplanted for more than 3 months and their drug level was supposed to be at steady state. mmf concentration was measured with high- performance liquid chromatography (hplc). results: the plasma mpa concentration-time curve was characterized by an early sharp peak at about 1 hour postdose. the mean area under curve (auc), cmax and tmax were 47.0±18.3 µg.h/ml, 18.6±8.5 µg/ml and 1.0±0.5 hours respectively. conclusion: the plasma mpa concentration-time curve pattern of iranian patients was similar and consistent with previously reported profiles in other populations taking the same dose.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Impact of UGT1A9 Polymorphism on Mycophenolic Acid Pharmacokinetic Parameters in Stable Renal Transplant Patients

There are wide individual differences in pharmacokinetic parameters of mycophenolate mofetil (MMF) among transplanted patients. Some studies have shown that single nucleotide polymorphisms (SNPs) of the Uridine Diphosphate Glucuronosyl Transferase1A9 (UGT1A9) are responsible for these differences in early days after transplantation. Therefore it was decided to evaluate the influence of UGT poly...

full text

Impact of UGT1A9 Polymorphism on Mycophenolic Acid Pharmacokinetic Parameters in Stable Renal Transplant Patients

There are wide individual differences in pharmacokinetic parameters of mycophenolate mofetil (MMF) among transplanted patients. Some studies have shown that single nucleotide polymorphisms (SNPs) of the Uridine Diphosphate Glucuronosyl Transferase1A9 (UGT1A9) are responsible for these differences in early days after transplantation. Therefore it was decided to evaluate the influence of UGT poly...

full text

Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients.

To assess the influence of cyclosporin A (CsA) and tacrolimus (FK506) on mycophenolic acid (MPA) and correlation analysis of the pharmacokinetic parameters and patient characteristics, clinical outcome in Chinese kidney transplant recipients, the pharmacokinetics of 1000 mg mycophenolate mofetil (MMF) twice daily was measured by high-performance liquid chromatography (HPLC). PKS (Pharmaceutical...

full text

Mycophenolic Acid pharmacokinetics early after kidney transplant.

OBJECTIVES To determine the mycophenolic acid pharmacokinetic profile early after transplant in Iranian kidney graft recipients. MATERIALS AND METHODS A cross-sectional study was performed during 6 months in 31 patients who recently had kidney transplant and received fixed doses of mycophenolate mofetil (2 g/d). The plasma levels of mycophenolic acid were determined by high performance liquid...

full text

Effect of Ganciclovir on Pharmacokinetics of Mycophenolic Mofetil, in Kidney Transplant Patients

ObjectiveMycophenolate mofetil (MMF) is commonly administered concomitantly with ganciclovir for managingtransplant recipients who infected with CMV. This study was conducted to evaluate the probable effects ofganciclovir on Mycophenolic acid (MPA) pharmacokinetic.Materials and MethodsTen kidney transplant recipients who full field inclusion and exclusion criterias enrolled in this study. Thefi...

full text

Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil.

BACKGROUND Mycophenolate mofetil (MMF) is widely used in organ transplantation to prevent acute rejection. Because MMF can produce hematologic and/or gastrointestinal toxicity, therapeutic monitoring is becoming mandatory. This study was designed to investigate the relationship between the clinical events and the pharmacokinetics of mycophenolic acid (MPA) in adult renal transplantation. METH...

full text

My Resources

Save resource for easier access later


Journal title:
journal of pharmaceutical care

جلد ۱، شماره ۱، صفحات ۱۳-۱۸

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023